NCT06089902

Brief Summary

Anomalous aortic origin of a coronary artery (AAOCA) is a group of rare congenital heart defects with various clinical presentations. The lifetime-risk of an individual living with AAOCA is unknown, and data from multicentre registries are urgently needed to adapt current recommendations and guide optimal patient management. The European Registry for AAOCA (EURO-AAOCA) aims to assess differences with regard to AAOCA management between centres.

Trial Health

80
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
500

participants targeted

Target at P75+ for all trials

Timeline
33mo left

Started Jan 2019

Longer than P75 for all trials

Geographic Reach
2 countries

2 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress73%
Jan 2019Jan 2029

Study Start

First participant enrolled

January 1, 2019

Completed
4.8 years until next milestone

First Submitted

Initial submission to the registry

October 3, 2023

Completed
16 days until next milestone

First Posted

Study publicly available on registry

October 19, 2023

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2025

Completed
4 years until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2029

Expected
Last Updated

October 19, 2023

Status Verified

October 1, 2023

Enrollment Period

6 years

First QC Date

October 3, 2023

Last Update Submit

October 11, 2023

Conditions

Keywords

anomalouscoronarysudden cardiac death

Outcome Measures

Primary Outcomes (3)

  • Incidence of Symptoms at diagnosis and after surgery

    The study will assess the presence of symptoms (angina, chest pain, distress, sudden cardiac death-SCD, syncope, aborted SCD) at diagnosis, and after eventual surgical repair, to assess incidence of symptoms in patients with this anomaly and effectiveness of surgery in removing symptoms.

    5 years

  • Incidence of postoperative adverse events

    The study will assess the incidence of operative death and adverse events after surgery (in those who undergo surgery).

    5 years

  • Incidence of adverse events at follow up

    The study will assess the incidence of death and adverse events at clinical follow up either in patients who required a surgical repair or in those who did not undergo surgery because of lack of indications.

    5 years

Secondary Outcomes (2)

  • Incidence of any arrhythmias at Follow up

    5 years

  • Rate of return to unrestricted competitive sport

    5 years

Study Arms (2)

adult > 30 years

All adult patient \> 30 yrs undergoing diagnosis (incidental or not) of anomalous aortic origin of coronary arteries

Procedure: unroofing or other surgery if needed

Juvenile < 30 yrs

All young patient \<30 yrs undergoing diagnosis (incidental or not) of anomalous aortic origin of coronary arteries

Procedure: unroofing or other surgery if needed

Interventions

unroofing of coronary artery

Also known as: clinical follow up
Juvenile < 30 yrsadult > 30 years

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

all patients undergoing incidental or not diagnosis of AAOCA

You may qualify if:

  • All patients with a diagnosis of AAOCA (either referred to surgery or to medical follow-up )

You may not qualify if:

  • isolated high-coronary take-off (≥ 5mm above sino-tubular junction), anomalous origin of a circumflex from the right coronary artery, anomalous course with a normal origin, and association to major congenital heart disease (i.e. Tetralogy of Fallot, transposition of the great arteries, anomalous origin of a coronary from the pulmonary artery).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Massimo Padalino

Padua, PD, 35128, Italy

RECRUITING

Christopher Grani

Bern, Switzerland

RECRUITING

Related Publications (6)

  • Padalino MA, Jegatheeswaran A, Blitzer D, Ricciardi G, Guariento A. Surgery for Anomalous Aortic Origin of Coronary Arteries: Technical Safeguards and Pitfalls. Front Cardiovasc Med. 2021 May 12;8:626108. doi: 10.3389/fcvm.2021.626108. eCollection 2021.

  • Bigler MR, Kadner A, Raber L, Ashraf A, Windecker S, Siepe M, Padalino MA, Grani C. Therapeutic Management of Anomalous Coronary Arteries Originating From the Opposite Sinus of Valsalva: Current Evidence, Proposed Approach, and the Unknowing. J Am Heart Assoc. 2022 Oct 18;11(20):e027098. doi: 10.1161/JAHA.122.027098. Epub 2022 Oct 7.

  • Ponzoni M, Frigo AC, Padalino MA. Surgery for Anomalous Aortic Origin of a Coronary Artery (AAOCA) in Children and Adolescents: A Meta-Analysis. World J Pediatr Congenit Heart Surg. 2022 Jul;13(4):485-494. doi: 10.1177/21501351221095424.

  • Grani C, Padalino MA. Editorial: Coronary Artery Anomalies: A 2020 Review. Front Cardiovasc Med. 2022 Feb 10;9:776951. doi: 10.3389/fcvm.2022.776951. eCollection 2022. No abstract available.

  • Thiene G, Frescura C, Padalino M, Basso C, Rizzo S. Coronary Arteries: Normal Anatomy With Historical Notes and Embryology of Main Stems. Front Cardiovasc Med. 2021 May 31;8:649855. doi: 10.3389/fcvm.2021.649855. eCollection 2021.

  • Padalino MA, Franchetti N, Hazekamp M, Sojak V, Carrel T, Frigiola A, Lo Rito M, Horer J, Roussin R, Cleuziou J, Meyns B, Fragata J, Telles H, Polimenakos AC, Francois K, Veshti A, Salminen J, Rocafort AG, Nosal M, Vedovelli L, Guariento A, Vida VL, Sarris GE, Boccuzzo G, Stellin G. Surgery for anomalous aortic origin of coronary arteries: a multicentre study from the European Congenital Heart Surgeons Associationdagger. Eur J Cardiothorac Surg. 2019 Oct 1;56(4):696-703. doi: 10.1093/ejcts/ezz080.

MeSH Terms

Conditions

Heart Defects, CongenitalDeath, Sudden, CardiacDiseaseArrhythmias, Cardiac

Condition Hierarchy (Ancestors)

Cardiovascular AbnormalitiesCardiovascular DiseasesHeart DiseasesCongenital AbnormalitiesCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesHeart ArrestDeath, SuddenDeathPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Massimo Padalino, MD PhD

    University of Padova

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Massimo Padalino, MD PhD

CONTACT

Chris Grani, MD PhD

CONTACT

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Target Duration
5 Years
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

October 3, 2023

First Posted

October 19, 2023

Study Start

January 1, 2019

Primary Completion

January 1, 2025

Study Completion (Estimated)

January 1, 2029

Last Updated

October 19, 2023

Record last verified: 2023-10

Data Sharing

IPD Sharing
Will not share

The anonymized demographic and clinical data underlying this study can be shared on reasonable request to the principal investigator

Locations